Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Klotho Neurosciences, Inc.

Klotho Neurosciences, Inc. (KLTO) Stock Overview

Explore Klotho Neurosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

KLTO●NASDAQ
HealthcareBiotechnology
$0.38
$0.03(7.10%)
U.S. Market opens in 47h 4m

Klotho Neurosciences, Inc. (KLTO)

Meyka AI Score

Z

Key Financials

Market Cap20.1M
P/E Ratio-1.13
EPS (TTM)$-0.30
ROE-1.09%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.28

KLTO Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Klotho Neurosciences, Inc. (NASDAQ: KLTO) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Klotho Neurosciences, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of KLTO on the NASDAQ shows an RSI of 0.00, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $0.28 for the NASDAQ listing.

Key metrics behind Klotho Neurosciences, Inc.'s NASDAQ-traded stock include a P/E ratio of -1.13 and a market capitalization of 20.1M. Combined with our AI analysis, these give both institutional and retail investors a clear view of KLTO on the NASDAQ.

Price Performance (NASDAQ: KLTO)

1-Day Change
10.15%
5-Day Change
-11.40%
1-Month Change
-7.10%
3-Month Change
21.65%
6-Month Change
-42.26%
Year-to-Date (YTD) Change
31.83%
1-Year Change
116.48%
3-Year Change
-63.01%
5-Year Change
-63.01%
All-Time (Max) Change
-63.01%

Contact Information

https://greenlandmines.com
833 931 6330
13576 Walnut Street, Omaha, NE, 68144

Company Facts

30 Employees
IPO DateApr 29, 2022
CountryUS

Frequently Asked Questions